{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:55:26Z","timestamp":1789970126027,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1888,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/jto.0b013e3181f23f04","type":"journal-article","created":{"date-parts":[[2010,9,21]],"date-time":"2010-09-21T07:29:35Z","timestamp":1285054175000},"page":"S277-S280","source":"Crossref","is-referenced-by-count":63,"special_numbering":"S4","title":["Caspr2 Antibodies in Patients with Thymomas"],"prefix":"10.1016","volume":"5","author":[{"given":"Angela","family":"Vincent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarosh R.","family":"Irani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e3181f23f04_bib1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archneur.57.4.527","article-title":"Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia","volume":"57","author":"Mygland","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib3","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of myasthenia gravis","volume":"2","author":"Vincent","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib4","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410380505","article-title":"Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves","volume":"38","author":"Shillito","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ana.410410215","article-title":"Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia","volume":"41","author":"Hart","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib6","first-page":"257","article-title":"What is left of Morvan's fibrillary chorea?","volume":"150","author":"Serratrice","year":"1994","journal-title":"Rev Neurol (Paris)"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/jnnp.65.6.857","article-title":"Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma","volume":"65","author":"Lee","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib8","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00004691-200411000-00008","article-title":"Neurophysiologic studies in Morvan syndrome","volume":"21","author":"Josephs","year":"2004","journal-title":"J Clin Neurophysiol"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib9","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1093\/brain\/124.12.2417","article-title":"Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels","volume":"124","author":"Liguori","year":"2001","journal-title":"Brain"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib10","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/01.wnl.0000336972.62597.41","article-title":"Immunotherapy-reversed compulsive, monoaminergic, circadian rhythm disorder in Morvan syndrome","volume":"71","author":"Spinazzi","year":"2008","journal-title":"Neurology"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1212\/WNL.54.3.771","article-title":"Morvan's syndrome associated with voltage-gated K+ channel antibodies","volume":"54","author":"Barber","year":"2000","journal-title":"Neurology"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/brain\/83.3.357","article-title":"Subacute encephalitis of later adult life mainly affecting the limbic areas","volume":"83","author":"Brierley","year":"1960","journal-title":"Brain"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib13","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","article-title":"Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients","volume":"123","author":"Gultekin","year":"2000","journal-title":"Brain"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib14","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib15","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1212\/01.WNL.0000122648.19196.02","article-title":"Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody","volume":"62","author":"Thieben","year":"2008","journal-title":"Neurology"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib16","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1212\/01.wnl.0000326572.93762.51","article-title":"Immunotherapy-responsive seizure-like episodes with potassium channel antibodies","volume":"71","author":"Irani","year":"2008","journal-title":"Neurology"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.1097","article-title":"Potassium channel antibodies in two patients with reversible limbic encephalitis","volume":"50","author":"Buckley","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib18","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/brain\/awf178","article-title":"Phenotypic variants of autoimmune peripheral nerve hyperexcitability","volume":"125","author":"Hart","year":"2002","journal-title":"Brain"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins Lgi1 and Caspr2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib20","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","article-title":"N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib21","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.65.7.913","article-title":"Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis","volume":"65","author":"Waters","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib22","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib23","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1523\/JNEUROSCI.4661-09.2010","article-title":"ADAM22, a Kv1 channel-interacting protein, recruits membrane-associated guanylate kinases to juxtaparanodes of myelinated axons","volume":"30","author":"Ogawa","year":"2010","journal-title":"J Neurosci"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0959-4388(00)00122-7","article-title":"Molecular domains of myelinated axons","volume":"10","author":"Peles","year":"2000","journal-title":"Curr Opin Neurobiol"},{"key":"10.1097\/JTO.0b013e3181f23f04_bib25","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1083\/jcb.200305018","article-title":"Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1","volume":"162","author":"Poliak","year":"2003","journal-title":"J Cell Biol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415326162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415326162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T19:56:43Z","timestamp":1559678203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415326162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1556086415326162"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e3181f23f04","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}